Roughly 30% to 40% of all patients with HCC will have negative serum levels of AFP, and 15% to 30% of patients with advanced HCC will initially have elevated serum AFP levels that subsequently return to normal values (5, 6). The gene discussed is AFP; the disease is hepatocellular carcinoma.